1-(10h-phenothiazin-2-yl)ethanone and fibrinogen

1-(10h-phenothiazin-2-yl)ethanone has been researched along with fibrinogen in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Caggiano, L; Celikag, M; Ferreira, B; Gulacsy, CE; Hounslea, E; Koeners, MP; Patinha, D; Pula, G; Tarafdar, A; Vara, D; Warren, Z	1

Other Studies

1 other study(ies) available for 1-(10h-phenothiazin-2-yl)ethanone and fibrinogen

Article	Year
NADPH oxidase 1 is a novel pharmacological target for the development of an antiplatelet drug without bleeding side effects. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:10 Topics: Animals; Carotid Artery Thrombosis; Cells, Cultured; Collagen; Enzyme Inhibitors; Female; Fibrinogen; Hemorrhage; Humans; Mice; Mice, Inbred C57BL; NADPH Oxidase 1; Phenothiazines; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Thrombin	2020

Article

Year

NADPH oxidase 1 is a novel pharmacological target for the development of an antiplatelet drug without bleeding side effects.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:10

Topics: Animals; Carotid Artery Thrombosis; Cells, Cultured; Collagen; Enzyme Inhibitors; Female; Fibrinogen; Hemorrhage; Humans; Mice; Mice, Inbred C57BL; NADPH Oxidase 1; Phenothiazines; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Thrombin

2020